Products containing synthetic cannabinoids and psychosis

被引:14
|
作者
Brakoulias, Vlasios [1 ,2 ]
机构
[1] Univ Sydney, Discipline Psychiat, Penrith, NSW 2751, Australia
[2] Nepean Hosp, Penrith, NSW, Australia
来源
关键词
SPICE;
D O I
10.1177/0004867411433974
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:281 / 282
页数:2
相关论文
共 50 条
  • [41] Synthetic cannabinoids and driving
    Mura, Patrick
    Brunet, Bertrand
    TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2015, 27 (01) : 41 - 44
  • [42] Nonpsychotropic synthetic cannabinoids
    Pop, E
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (13) : 1347 - 1359
  • [43] Cathinones and synthetic cannabinoids
    Preuss, Ulrich W.
    Schoett, Katharina
    SUCHTTHERAPIE, 2022, 23 (02) : 94 - 104
  • [44] Toxicology of synthetic cannabinoids
    Moutaouakkil, Youssef
    Mounir, Radia
    El Cadi, Mina Ait
    Lamsaouri, Jamal
    Bousliman, Yassir
    Eljaoudi, Rachid
    ANNALES DE BIOLOGIE CLINIQUE, 2024, 82 (02) : 151 - 173
  • [45] Synthetic cannabinoids in the kidneys
    Alp, Alper
    Akdam, Hakan
    Avcioglu, Banu Yilmaz
    Ersan, Sibel
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (01): : 10 - 12
  • [46] Synthetic cannabinoids - Preface
    Pop, E
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (13) : U2 - U2
  • [47] Regulation of synthetic cannabinoids
    Sumnall, Harry
    LANCET, 2009, 374 (9701): : 1595 - 1595
  • [48] The Synthetic Cannabinoids Phenomenon
    Karila, Laurent
    Benyamina, Amine
    Blecha, Lisa
    Cottencin, Olivier
    Billieux, Joel
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (42) : 6420 - 6425
  • [49] Variation in commercial smoking mixtures containing third-generation synthetic cannabinoids
    Frinculescu, Anca
    Lyall, Catherine L.
    Ramsey, John
    Miserez, Bram
    DRUG TESTING AND ANALYSIS, 2017, 9 (02) : 327 - 333
  • [50] Human Laboratory Studies on Cannabinoids and Psychosis
    Sherif, Mohamed
    Radhakrishnan, Rajiv
    D'Souza, Deepak Cyril
    Ranganathan, Mohini
    BIOLOGICAL PSYCHIATRY, 2016, 79 (07) : 526 - 538